WAM
NAMSW icon

Wolverine Asset Management’s NewAmsterdam Pharma Warrant NAMSW Stock Holding History

Wolverine Asset Management’s Portfolio NAMSW Stock Details NAMSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$319K Buy
14,925
+12,798
+602% +$280K ﹤0.01% 1039
2026
Q1 		$42.6K Buy
+2,127
New +$44.2K ﹤0.01% 1276
2025
Q3 		– Sell
-2,091
Closed -$16.7K – 1756
2025
Q2 		$16.7K Sell
2,091
-6,793
-76% -$56.5K ﹤0.01% 1332
2025
Q1 		$79.9K Sell
8,884
-3,809
-30% -$41.6K ﹤0.01% 1120
2024
Q4 		$181K Buy
+12,693
New +$137K ﹤0.01% 1043
2023
Q3 		– Sell
-12,448
Closed -$26K – 1935
2023
Q2 		$26K Buy
+12,448
New +$26.8K ﹤0.01% 1247
2023
Q1 		– Sell
-1,462
Closed -$1.27K – 2013
2022
Q4 		$1.27K Buy
+1,462
New +$1.2K ﹤0.01% 1922

Other funds holding NAMSW

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
VI
Vestcor Inc Fredericton, New Brunswick, Canada $4.05B AUM 34.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wolverine Asset Management's NAMSW Position: Q2 2026 in Review

Wolverine Asset Management increased its NewAmsterdam Pharma Warrant (NAMSW) stake by 602% in Q2 2026, buying an estimated $280K and bringing the position to 14,925 shares worth $319K. The position accounts for ﹤0.01% of the portfolio, ranked #1039.

Wolverine Asset Management first reported a position in NAMSW in Q4 2022 and has held it in 7 quarters since. 9 funds tracked by Wall St. Rank hold NAMSW as of Q2 2026.

  • Wolverine Asset Management held 14,925 shares of NewAmsterdam Pharma Warrant worth $319K as of Q2 2026.
  • Wolverine Asset Management bought 12,798 NewAmsterdam Pharma Warrant shares in Q2 2026, an estimated $280K.
  • NewAmsterdam Pharma Warrant made up ﹤0.01% of Wolverine Asset Management's portfolio in Q2 2026, its #1039 holding.
  • Wolverine Asset Management first reported a position in NewAmsterdam Pharma Warrant in Q4 2022 and has held it in 7 quarters since.
  • 9 funds tracked by Wall St. Rank held NewAmsterdam Pharma Warrant as of Q2 2026.

Based on Wolverine Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.